Study S001937

Semaglutide and Physical Activity for Obesity and Multimorbidity: Co-designing Healthy Healthcare

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06234111
Study type: OBSERVATIONAL
Status: ACTIVE_NOT_RECRUITING
Enrollment: 35
Start: 2024-02-20
Primary completion: 2026-10
Lead sponsor: Hvidovre University Hospital
Conditions: Obesity Morbid; Multimorbidity; Obesity
Interventions: COMBINATION_PRODUCT:Semaglutide 2.4 mg, total diet replacement, behavioural intervention
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Habitual physical activity [Baseline (± 2 weeks), 4 months (± 2 weeks) and 24 months (± 2 weeks).]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0005294	Exploring Cardiometabolic Health, Physical Activity, and Quality of Life in Patients with Obesity and Multimorbidity during an Intensive Weight Loss Program: A Protocol for a Real-Life Prospective Cohort Study Brødsgaard RH, medRxiv	2025	Protocol	DOI	cites ClinicalTrials.gov:NCT06234111